Related Experiment Videos
Aggressive oligodendroglioma predicted by chromosome 10 restriction fragment length polymorphism analysis. Case study
1Department of Neurosurgery, New England Medical Center, Boston, Massachusetts.
Journal of Neuro-Oncology
|January 1, 1993
Summary
Loss of chromosome 10 in oligodendroglioma may indicate aggressive brain tumor behavior. This finding, typically seen in glioblastoma, suggests a need for tailored treatments for patients with this genetic marker.
Area of Science:
- Neuro-oncology
- Cancer Genetics
- Molecular Pathology
Background:
- Oligodendrogliomas are typically slow-growing brain tumors with variable survival rates.
- Tumor heterogeneity suggests differences in biologic behavior and prognosis.
- Genetic alterations are increasingly recognized as key drivers of tumor progression.
Observation:
- A case of oligodendroglioma exhibited loss of chromosome 10 sequences.
- This genetic abnormality (loss of chromosome 10) is usually associated with more aggressive brain tumors like glioblastoma multiforme.
- The patient later presented with a recurrent tumor displaying features of glioblastoma multiforme.
Findings:
- Loss of chromosome 10 alleles in oligodendroglioma may serve as a predictive marker for aggressive biologic behavior.
- This genetic indicator of aggressiveness can be present even without overt histopathologic signs of anaplasia.
- Restriction fragment length polymorphism (RFLP) analysis was used to detect the chromosomal loss.
Implications:
- Identifying oligodendrogliomas with chromosome 10 loss could enable earlier detection of aggressive potential.
- This may facilitate the selection of more appropriate and potentially intensive treatment strategies for affected patients.
- Understanding genetic markers like chromosome 10 loss can refine prognostication and personalized medicine approaches in neuro-oncology.